Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
June 2013 Volume 5 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
June 2013 Volume 5 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

The effect of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats

  • Authors:
    • Jing-Shu Xu
    • Yao Li
    • Xue Cao
    • Yun Cui
  • View Affiliations / Copyright

    Affiliations: Department of Oral Medicine, Kunhua Hospital, The First People's Hospital of Yunnan, Kunming, Yunnan 650032, P.R. China
  • Pages: 1667-1670
    |
    Published online on: April 17, 2013
       https://doi.org/10.3892/etm.2013.1066
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Eugenol has been widely used in medicine due to its antibacterial, anti-inflammatory, antioxidant, anticancer and analgesic properties. The present study was designed to investigate the effects of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats. Eugenol demonstrated significant inhibitory effects against acid production by S. mutans. The synthesis of water-insoluble glucans by glucosyltransferases was reduced by eugenol. Eugenol also markedly suppressed the adherence of S. mutans to saliva-coated hydroxyapatite beads. Furthermore, topical application of eugenol reduced the incidence and severity of carious lesions in rats. These results suggest that the natural compound eugenol may be a useful therapeutic agent for dental caries.

Introduction

Dental caries is a prevalent oral infectious disease, which is associated with various pathogenic microorganisms, including Streptococcus mutans and Streptococcus sobrinus. S. mutans is considered a crucial pathogen in the pathogenesis of dental caries (1). S. mutans produces glucosyltransferases (Gtfs) and synthesizes glucans from sucrose. Glucans are critical for bacterial accumulation on the tooth surface and the formation of cariogenic biofilms (2). Furthermore, S. mutans survive at low pH values and generate acids that result in the demineralization of tooth enamel, thereby initiating dental caries (3). Therefore, it has been proposed that disruption of the ability of S. mutans to form acids and glucans is an effective therapeutic approach for the treatment of dental caries.

Eugenol (4-allyl-2-methoxyphenol) is an aromatic molecule found in essential oils and various plants, including cloves, bay leaves and cinnamon leaves. Numerous studies have reported that eugenol possesses antibacterial, antiviral, antioxidant, anti-inflammatory and analgesic effects (4–6). Eugenol has been widely used in dentistry to treat toothache and pulpitis (7). A previous study indicated that eugenol may be an ideal natural agent for use in oral care products. Eugenol inhibits the growth and insoluble and soluble glucan synthesis of S. sobrinus (8). However, the therapeutic effect of eugenol against dental caries has not been thoroughly evaluated. Therefore, the aims of this study were: i) to examine the effects of eugenol on the adherence, acid production and insoluble glucan synthesis of S. mutans in vitro and ii) to determine the inhibitory effects of eugenol on caries development in vivo.

Materials and methods

Reagents

Eugenol and sodium fluoride were purchased from Sigma (St. Louis, MO, USA). Hydroxyapatite beads were obtained from Bio-Rad (Hercules, CA, USA). All other chemicals were of analytical grade and commercially available.

Measurement of acid production by S. mutans 25175

Acid production was performed as described previously with slight modifications (9). Briefly, eugenol was added to 0.95 ml phenol red broth containing 1% glucose. Then, the mixture was inoculated with 0.05 ml S. mutans 25175 seed culture. After incubation at 37°C for 24 h, the pH values of the cultures were measured using a pH meter.

Measurement of water-insoluble glucan synthesis by Gtfs

S. mutans 25175 was cultured at 37°C for 24 h in tryptic soy broth. The culture supernatant was salted out with solid ammonium sulfate to 70% saturation and then agitated at 4°C for 1 h. After centrifugation at 13,500 × g for 20 min, the precipitate was dialyzed against 10 mM potassium phosphate buffer (pH 6.0). The crude Gtfs preparation was stored at −80°C until further analysis.

Reaction mixtures consisting of 0.025 ml crude Gtfs preparation and 0.175 ml eugenol (final concentration, 0, 4, 8 and 16 mg/ml) in 0.8 ml 0.0625 M potassium phosphate buffer containing 12.5 μg/l sucrose and 0.25 μg/l sodium azide were incubated at 37°C for 18 h. The water-insoluble glucan was sedimented and washed with distilled water and then ultrasonicated for 6 sec. The absorbance was examined at 550 nm against a blank control.

Bacterial adherence assay

The bacterial adherence assay was performed as described previously (12). Briefly, S. mutans 25175 was diluted in tryptic soy broth at a density of 108 colony-forming units (CFU) per milliliter. Human saliva was collected from an adult donor and clarified by centrifugation. Hydroxyapatite beads were treated with clarified human saliva and rotated at 7 × g for 1 h at room temperature. The saliva-coated hydroxyapatite beads (S-HAs) were washed three times with 0.01 M potassium phosphate buffer (pH 7.0). Bacterial suspensions with or without various concentrations of added eugenol were incubated with the S-HAs at 37°C for 90 min and then the S-HAs were washed three times with potassium phosphate buffer. The detached cells on S-HAs were dispersed, diluted and spread on Mitis Salivarius agar plates containing bacitracin (3.2 mg/ml). The number of bacterial colonies was counted on each plate after incubation at 37°C for 48 h and the CFU were then calculated.

Animal experiments

The animal experiments were performed as described previously (10,11). Briefly, specific pathogen-free male Wistar rats (aged 19 days; Kunming Medical University, Kunming, China) were infected daily for five consecutive days with a growing culture of S. mutans 25175. Rats aged 25 days were randomly divided into three groups (n=15) and their teeth were treated topically using a camel hair brush twice daily for 5 weeks, as follows: i) vehicle control [15% ethanol containing 1% dimethylsulfoxide (DMSO)], ii) 16 mg/ml eugenol and iii) 250 ppm fluoride. The rats were provided with cariogenic diet 2000 and 5% sucrose water ad libitum. At the end of the 5-week experimental period, the rats were deeply anesthetized and sacrificed. The lower left jaw was collected aseptically, immerged in 5.0 ml sterile saline solution and sonicated. The suspension was plated on blood agar and on Mitis Salivarius agar plus streptomycin to respectively estimate the number of total cultivable microorganisms and S. mutans populations. The smooth-surface and sulcal caries and their severities (Ds, dentin exposed; Dm, 3/4 of the dentin affected; Dx, whole dentin affected) were evaluated by means of Larson’s modification of Keyes’s system (11,12). The caries score was determined blindly with respect to the groups. All procedures were performed in accordance with guidelines set for the use of experimental animals by the Committee on Animal Care and Use of Kunhua Hospital (Kunming, China).

Statistical analysis

All values are expressed as the mean ± standard error of the mean (SEM). The data were analyzed by analysis of variance (ANOVA) followed by Tukey-Kramer multiple comparisons test using SPSS software (SPSS, Inc., Chicago, IL, USA). P<0.05 was considered to indicate a statistically significant difference.

Results

In vitro effect of eugenol on the cariogenic properties of S. mutans

In this study, we firstly investigated the inhibitory effect of eugenol on acid production by S. mutans 25175. The cells were treated with various concentrations of eugenol and the pH was then measured. As shown in Fig. 1, the acid production was significantly suppressed by eugenol compared with the control group.

Figure 1

Effects of eugenol on acid production by Streptococcus mutans 25175. The assay was performed in triplicate and data are presented as mean ± standard error of the mean (SEM). *P<0.05, compared with the control.

To assess the effects of eugenol on the adherence of S. mutans 25175, a bacterial adherence assay was performed. As shown in Fig. 2, eugenol significantly inhibited the adherence of S. mutans to S-HAs in a concentration-dependent manner.

Figure 2

Effect of eugenol on the cell adherence of Streptococcus mutans 25175. The number of colony forming units (CFU) of S. mutans adhering to saliva-coated hydroxyapatite beads at various concentrations of eugenol was measured. The assay was performed in triplicate and data are presented as mean ± standard error of the mean (SEM). *P<0.05, compared with the control.

We also examined whether eugenol suppresses the synthesis of water-insoluble glucans by crude Gtfs. As shown in Fig. 3, a significant reduction in water-insoluble glucan synthesis by crude Gtfs from S. mutans was observed at concentrations of 4–16 mg/ml eugenol.

Figure 3

Effect of eugenol on insoluble glucan synthesis by glucosyltransferases (Gtfs) of Streptococcus mutans 25175. The amount (%) of insoluble glucan produced by various concentrations of eugenol was determined relative to the control. The assay was performed in triplicate and data are presented as mean ± standard error of the mean (SEM). *P<0.05, compared with the control.

Inhibitory effects of eugenol on dental caries development in rats

In the animal experiment, the rats remained in good health and gained weight during the 5 weeks of the study. No significant differences in weight gain were identified among the groups (P>0.05, data not shown).

The effects of eugenol on the total cultivable flora, S. mutans viable populations and percentage of S. mutans recovered from the rat jaws (as calculated from total cultivable flora, S. mutans population) are shown in Table I. The eugenol-treated group exhibited significantly lower total flora counts compared with the vehicle control. However, the number of CFUs and percentage of S. mutans in the biofilms of the rats treated with eugenol did not differ significantly from those of the vehicle control.

Table I

Effects of eugenol on oral microbiota in rats after a 5-week experiment.

Table I

Effects of eugenol on oral microbiota in rats after a 5-week experiment.

GroupTotal microorganisms (×104 CFU/ml)Streptococcus Mutans 25175 (×104 CFU/ml)Streptococcus Mutans 25175 (%)
Vehicle4.3a (1.6)3.0a (1.8)69.9a (20.1)
Eugenol (16 mg/ml)2.4b (0.6)1.6a (0.4)67.7a (18.4)
250 ppm fluoride2.2b (0.5)1.7a (0.3)77.3a (16.2)

[i] Statistical analyses for all pairs was performed using Tukey-Kramer multiple comparisons test (n=15). Fluoride was used as a positive control. Values followed by different lower case letters (vertical) are significantly different from each other (P<0.05). CFU, colony forming units.

Tables II and III show the incidence and severity of smooth-surface and sulcal caries. In the present study, 250 ppm fluoride was used as a positive control. The 250 ppm fluoride treatment produced the lowest scores for incidence and severity of smooth-surface and sulcal caries. Eugenol treatment significantly reduced the incidence of smooth-surface and sulcal caries compared with the vehicle control. Furthermore, the severity scores of smooth-surface and sulcal caries were significantly lower in the eugenol-treated group compared with those in the vehicle control group.

Table II

Effects of treatments on dental caries development (smooth surface and severity) in rats.

Table II

Effects of treatments on dental caries development (smooth surface and severity) in rats.

GroupSmooth surface totalSeverity
DsDmDx
Vehicle63.1a (5.7)41.6a (6.7)18.7a (4.3)7.4a (5.1)
Eugenol (16 mg/ml)39.2b (5.2)22.1b (4.8)4.8b (5.8)2.0b (0.8)
250 ppm fluoride23.2c (3.1)17.7b (5.7)0.7b (0.5)0.1c (0.4)

[i] Statistical analyses for all pairs was performed using Tukey-Kramer multiple comparisons test (n=15). Values followed by different lower case letters (vertical) are significantly different from each other (P<0.05). Ds, dentin exposed; Dm, 3/4 of the dentin affected; Dx, whole dentin affected.

Table III

Effects of treatments on dental caries development (sulcal surface and severity) in rats.

Table III

Effects of treatments on dental caries development (sulcal surface and severity) in rats.

GroupSulcal surface totalSeverity
DsDmDx
Vehicle37.8a (4.8)26.3a (4.5)20.3a (3.7)13.4a (2.2)
Eugenol (16 mg/ml)28.5b (3.8)16.7b (4.1)9.2b (3.6)5.9b (2.8)
250 ppm fluoride18.9c (3.1)9.5c (4.1)2.9c (1.4)0.3c (0.2)

[i] Statistical analyses for all pairs was performed using Tukey-Kramer multiple comparisons test (n=15). Values followed by different lower case letters (vertical) are significantly different from each other (P<0.05). Ds, dentin exposed; DM, 3/4 of the dentin affected; Dx, whole dentin affected.

Discussion

Despite advances in the development and improvement of anti-caries chemotherapy, conventional therapeutic strategies often fall short of the goal of controlling dental caries progression. The use of natural products has been reported to be one of the most successful strategies for the discovery of new medicines (11,13). Previous studies have shown that natural products are promising candidates for new anticariogenic substances (9,13). The present study demonstrated that eugenol, a naturally occurring agent, interferes with cariogenic factors of S. mutans, including acid production, adherence and water-insoluble glucan synthesis in vitro and inhibited the development of dental caries in rats.

Acid production is an important dental caries-related factor of S. mutans (14). In dental biofilms, S. mutans metabolize sugars to produce organic acids, including lactic acid, propionic acid and butyric acid, which may demineralize the tooth surface and thereby induce dental caries (3). In the present study, eugenol significantly inhibited the reduction of pH induced by S. mutans. These results suggest that eugenol may reduce acid production by S. mutans.

The adherence of S. mutans to the tooth surface is one of the most important steps for dental plaque formation (9,15). Disruption of the ability of S. mutans to adhere to the surface of the tooth is considered an important therapeutic approach for the prevention of plaque formation. Therefore, we investigated the effect of eugenol on the adhesion of S. mutans to S-HAs. At concentrations of 4–16 mg/ml, eugenol significantly reduces the adherence of S. mutans to S-HAs. These data suggest that eugenol may be a novel substance capable of modulating the activity of this important dental caries-related factor.

The synthesis of extracellular polysaccharides, including water-insoluble glucans, is one of the most important virulent properties of S. mutans (16). Water-insoluble glucans promote the adhesive interactions of bacteria with the tooth surface and contribute to the formation of dental biofilms (17). Accordingly, we examined whether eugenol inhibits the synthesis of water-insoluble glucans by crude Gtfs. The results showed that the formation of water-insoluble glucans by S. mutans was significantly suppressed in the presence of eugenol. Our results correlate well with other reports that eugenol suppresses the insoluble and soluble glucan synthesis of S. sobrinus (8,18). S. mutans synthesizes glucans from sucrose by the action of Gtfs. There are at least three types of Gtfs in S. mutans: Gtf B, Gtf C and Gtf D. It has been reported that Gtf B and C are important for the synthesis of insoluble glucans by S. mutans (19,20). Gtf B synthesizes primarily insoluble glucans, whereas Gtf C synthesizes insoluble and soluble glucans. Although we identified that eugenol inhibits water-insoluble glucan synthesis, it was not confirmed whether eugenol inhibits Gtf B and/or Gtf C. This requires further investigation.

The inhibitory effects of eugenol on the acid production, adherence and water-insoluble glucan synthesis activities of S. mutans may be beneficial for the prevention of caries development in vivo. Therefore, we examined the anti-caries activity of eugenol using a rat model of dental caries. Topical application of eugenol reduces the incidence and severity of carious lesions in rats without affecting the number and percentage of S. mutans in the biofilms. In smooth-surface caries, eugenol effectively reduced the number and severity of caries, with results similar to those of 250 ppm fluoride (the positive control). However, the inhibitory effects of eugenol in sulcal caries were not as effective as those exhibited by 250 ppm fluoride. These results suggest that eugenol is an effective agent for the inhibition of dental caries development in vivo. Natural products that inhibit cariogenic properties of S. mutans may be used to control dental caries or even to enhance the cariostatic effect of other recognized agents, including fluoride. Therefore, further studies are required to investigate the possible additive or synergistic anticariogenic effects of eugenol and fluoride.

In conclusion, our data demonstrated that eugenol significantly attenuates the acid production, adherence and water-insoluble glucan synthesis activities of S. mutans and suppresses dental caries development in rats. These results suggest that eugenol is a promising naturally occurring agent for the treatment of dental caries.

Acknowledgements

This study was supported by the Science and Technology Joint Special Fund of Yunnan Province (2011FB220).

References

1. 

Loesche WJ: Role of Streptococcus mutans in human dental decay. Microbiol Rev. 50:353–380. 1986.

2. 

Hamada S and Slade HD: Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev. 44:331–384. 1980.PubMed/NCBI

3. 

Belli WA and Marquis RE: Adaptation of Streptococcus mutans and Enterococcus hirae to acid stress in continuous culture. Appl Environ Microbiol. 57:1134–1138. 1991.PubMed/NCBI

4. 

Walsh SE, Maillard JY, Russell AD, Catrenich CE, Charbonneau DL and Bartolo RG: Activity and mechanisms of action of selected biocidal agents on Gram-positive and -negative bacteria. J Appl Microbiol. 94:240–247. 2003. View Article : Google Scholar : PubMed/NCBI

5. 

Chami N, Bennis S, Chami F, Aboussekhra A and Remmal A: Study of anticandidal activity of carvacrol and eugenol in vitro and in vivo. Oral Microbiol Immunol. 20:106–111. 2005. View Article : Google Scholar : PubMed/NCBI

6. 

Yeon KY, Chung G, Kim YH, et al: Eugenol reverses mechanical allodynia after peripheral nerve injury by inhibiting hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. Pain. 152:2108–2116. 2011. View Article : Google Scholar

7. 

Frisch J and Bhaskar SN: Tissue response to eugenol-containing periodontal dressings. J Periodontol. 38:402–408. 1967.PubMed/NCBI

8. 

Li MY, Lai GY, Wang J and Ye DX: The inhibition of eugenol on glucan is essential for the biofilm eradication effect on caries-related biofilm in an artificial mouth model. Nat Prod Res. 26:1152–1155. 2012. View Article : Google Scholar : PubMed/NCBI

9. 

Matsumoto M, Minami T, Sasaki H, Sobue S, Hamada S and Ooshima T: Inhibitory effects of oolong tea extract on caries-inducing properties of mutans streptococci. Caries Res. 33:441–445. 1999. View Article : Google Scholar : PubMed/NCBI

10. 

Bowen WH, Madison KM and Pearson SK: Influence of desalivation in rats on incidence of caries in intact cagemates. J Dent Res. 67:1316–1318. 1988. View Article : Google Scholar : PubMed/NCBI

11. 

Koo H, Pearson SK, Scott-Anne K, et al: Effects of apigenin and tt-farnesol on glucosyltransferase activity, biofilm viability and caries development in rats. Oral Microbiol Immunol. 17:337–343. 2002. View Article : Google Scholar : PubMed/NCBI

12. 

Fukushima K, Motoda R and Ikeda T: Effects of exogenous insoluble glucan primer on insoluble glucan synthesis by Streptococcus mutans. J Dent Res. 60:1707–1712. 1981. View Article : Google Scholar : PubMed/NCBI

13. 

Harvey A: Strategies for discovering drugs from previously unexplored natural products. Drug Discov Today. 5:294–300. 2000. View Article : Google Scholar : PubMed/NCBI

14. 

Kuramitsu HK: Virulence factors of mutans streptococci: role of molecular genetics. Crit Rev Oral Biol Med. 4:159–176. 1993.PubMed/NCBI

15. 

Westergren G and Olsson J: Hydrophobicity and adherence of oral streptococci after repeated subculture in vitro. Infect Immun. 40:432–435. 1983.PubMed/NCBI

16. 

Schilling KM and Bowen WH: Glucans synthesized in situ in experimental salivary pellicle function as specific binding sites for Streptococcus mutans. Infect Immun. 60:284–295. 1992.PubMed/NCBI

17. 

Madison KM, Bowen WH, Pearson SK and Falany JL: Enhancing the virulence of Streptococcus sobrinus in rats. J Dent Res. 70:38–43. 1991. View Article : Google Scholar

18. 

Li M and Liu Z: In vitro effect of Chinese herb extracts on caries-related bacteria and glucan. J Vet Dent. 25:236–239. 2008.PubMed/NCBI

19. 

Yamashita Y, Bowen WH, Burne RA and Kuramitsu HK: Role of the Streptococcus mutans gtf genes in caries induction in the specific-pathogen-free rat model. Infect Immun. 61:3811–3817. 1993.

20. 

Koo H, Xiao J, Klein MI and Jeon JG: Exopolysaccharides produced by Streptococcus mutans glucosyltransferases modulate the establishment of microcolonies within multispecies biofilms. J Bacteriol. 192:3024–3032. 2010.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Xu J, Li Y, Cao X and Cui Y: The effect of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats. Exp Ther Med 5: 1667-1670, 2013.
APA
Xu, J., Li, Y., Cao, X., & Cui, Y. (2013). The effect of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats. Experimental and Therapeutic Medicine, 5, 1667-1670. https://doi.org/10.3892/etm.2013.1066
MLA
Xu, J., Li, Y., Cao, X., Cui, Y."The effect of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats". Experimental and Therapeutic Medicine 5.6 (2013): 1667-1670.
Chicago
Xu, J., Li, Y., Cao, X., Cui, Y."The effect of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats". Experimental and Therapeutic Medicine 5, no. 6 (2013): 1667-1670. https://doi.org/10.3892/etm.2013.1066
Copy and paste a formatted citation
x
Spandidos Publications style
Xu J, Li Y, Cao X and Cui Y: The effect of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats. Exp Ther Med 5: 1667-1670, 2013.
APA
Xu, J., Li, Y., Cao, X., & Cui, Y. (2013). The effect of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats. Experimental and Therapeutic Medicine, 5, 1667-1670. https://doi.org/10.3892/etm.2013.1066
MLA
Xu, J., Li, Y., Cao, X., Cui, Y."The effect of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats". Experimental and Therapeutic Medicine 5.6 (2013): 1667-1670.
Chicago
Xu, J., Li, Y., Cao, X., Cui, Y."The effect of eugenol on the cariogenic properties of Streptococcus mutans and dental caries development in rats". Experimental and Therapeutic Medicine 5, no. 6 (2013): 1667-1670. https://doi.org/10.3892/etm.2013.1066
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team